|
2023
|
Invention
|
Treatment of hematological malignancies with antibodies inhibiting galectin-9. e.g.e.g.e.g., G9.2... |
|
|
Invention
|
Extracellular vesicles loaded with viral particles for cargo delivery. The present disclosure is ... |
|
|
Invention
|
Glycocalyx vesicles having surface modification of lectins for delivery of cargo to gastrointesti... |
|
2022
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof. Methods for treating solid tumors (e.g.,... |
|
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof. e.g.etcetc.) using an anti-Galectin-9 an... |
|
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof.
Disclosed herein are methods for treati... |
|
|
Invention
|
Combination of anti-galectin-9 antibodies and chemotherapeutics for use in cancer therapy.
Discl... |
|
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof. Disclosed herein are methods for treatin... |
|
|
Invention
|
Combination of anti-galectin-9 antibodies and chemotherapeutics for use in cancer therapy. Disclo... |
|
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof. e.g.e.g., pancreatic ductal adenocarcino... |
|
|
Invention
|
Combination of anti-galectin-9 antibodies and chemotherapeutics for use in cancer therapy. e.g.e.... |
|
2021
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof.
Combined therapy for a solid tumor, com... |
|
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof. e.g.e.g., G9.2-17), and one or more chem... |
|
|
Invention
|
Anti-galectin-9 antibodies and therapeutic uses thereof. e.g. e.g. , pancreatic adenocarcinoma (P... |
|
|
Invention
|
Anti-galectin-9 antibodies and uses thereof in the treatment of ocular melanoma.
Methods for tre... |
|
|
Invention
|
Anti-galectin-9 antibodies and uses thereof in the treatment of ocular melanoma. Methods for trea... |
|
|
Invention
|
Lipid prodrugs of neurosteroids. The present invention provides lymphatic system-directing lipid ... |
|
|
Invention
|
Vesicle compositions for oral delivery.
Cargo-loaded vesicles and compositions comprising such v... |
|
|
Invention
|
Vesicle compositions for oral delivery. Cargo-loaded vesicles and compositions comprising such ve... |
|
2020
|
Invention
|
Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeutics.
Combined therapy fo... |
|
|
Invention
|
Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeutics. Combined therapy for... |
|
|
Invention
|
Exosomes for delivery of therapeutic agents.
The present invention provides exosomes as drug del... |
|
|
Invention
|
Anti-galectin-9 antibodies and uses thereof.
Disclosed herein are methods for treating solid tum... |
|
|
Invention
|
Anti-galectin-9 antibodies and uses thereof.
Disclosed herein are methods for identifying a subj... |
|
|
Invention
|
Anti-galectin-9 antibodies and uses thereof. Disclosed herein are methods for treating solid tumo... |
|
|
Invention
|
Anti-galectin-9 antibodies and uses thereof.
Disclosed herein are anti-Galectin-9 antibodies and... |
|
|
Invention
|
Anti-galectin-9 antibodies and uses thereof. Disclosed herein are anti-Galectin-9 antibodies and ... |
|
|
Invention
|
Lipid prodrugs of jak inhibitors and uses thereof.
The present invention provides lymphatic syst... |
|
|
Invention
|
Lipid prodrugs of jak inhibitors and uses thereof. The present invention provides lymphatic syste... |
|
|
Invention
|
Lipid prodrugs of glucocorticoids and uses thereof. The present invention provides lymphatic syst... |
|
|
Invention
|
Lipid prodrugs of btk inhibitors and uses thereof. The present invention provides lymphatic syste... |
|
|
Invention
|
Antibodies specific to delta 1 chain of t cell receptor. Disclosed herein are antibodies specific... |
|
2019
|
Invention
|
Milk vesicles for use in delivering biological agents.
The present disclosure provides milk vesi... |
|
|
Invention
|
Milk vesicles for use in delivering biological agents. The present disclosure provides milk... |
|
2017
|
Invention
|
Exosomes for delivery of therapeutic agents. The present invention provides exosomes as drug deli... |
